However, in the NSABP-P1 study of tamoxifen in a high breast cancer risk population, against expectations, there was no association of oestradiol or SHBG with the risk of developing breast cancer and no indication of an interaction of these with tamoxifen’s preventive efficacy [51]. Here, SHBG is linked to breast cancer.